prostate cancer; Bovine growth hormone and breast cancer. The Ecologist 28(5), 268, 269. 36. The secret memoranda came to light as the result of a civil lawsuit spearheaded by lawyer Steven Druker against the US FDA, May 1998. For details see Biointegrity website: 37. Ewen, S.W.B. and Pusztai, A. (1999). Effects of diets containing genetially modified potatoes expressing Galanthus nivalis lectin on rat small intestine. The Lancet 354, 1353-1354; see also <>http://plab.ku.dk/tcbh/PusztaiPusztai.htm> 38. Pat Phibbs, P. (2000). Genetically modified food sales dead In EU Until safety certain, says consultant , The Bureau of National Affairs, Inc., Washington D.C. March 23, 2000. 39. See Ho, M.W. (1998,1999). Genetic Engineering Dream or Nightmare? The Brave New World of Bad Science and Big Business, Gateway, Gill & Macmillan, Dublin. 40. See Ho, M.W., Ryan, A., Cummins, J. (1999). The cauliflower mosaic viral promoter a recipe for disaster? Microbial Ecology in Health and Disease 11, 194-197; Ho, M.W., Ryan, A., Cummins, J. (2000). Hazards of transgenic crops with the cauliflower mosaic viral promoter. Microbial Ecology in Health and Disease (in press); Cummins, J., Ho, M.W. and Ryan, A. (2000). Hazards of CaMV promoter. Nature Biotechnology (in press). 41. Reviewed in Ho, 1998,1999 (note 37); Ho, M.W., Traavik, T., Olsvik, R., Tappeser, B., Howard, V., von Weizsacker, C. and McGavin, G. (1998b). Gene Technology and Gene Ecology of Infectious Diseases. Microbial Ecology in Health and Disease 10, 33-59; Traavik, T. (1999a). Too early may be too late, Ecological risks associated with the use of naked DNA as a biological tool for research, production and therapy, Research report for Directorate for Nature Management, Norway. 42. N Ballas, S Broido, H Soreq, A Loyter (1989) Efficient functioning of plant promoters and poly(A) sites in Xenopus oocytes Nucl Acids Res 17, 7891-903. 43. Burke, C, Yu X.B., Marchitelli, L.., Davis, E.A., Ackerman, S. (1990). Transcription factor IIA of wheat and human function similarly with plant and animal viral promoters. Nucleic Acids Res 18, 3611-20. 44. Reviewed in Ho, 1998,1999 (note 37); Ho, M.W., Traavik, T., Olsvik, R., Tappeser, B., Howard, V., von Weizsacker, C. and McGavin, G. (1998b). Gene Technology and Gene Ecology of Infectious Diseases. Microbial Ecology in Health and Disease 10, 33-59; Traavik, T. (1999a). Too early may be too late, Ecological risks associated with the use of naked DNA as a biological tool for research, production and therapy, Research report for Directorate for Nature Management, Norway. 45. Kumpatla, S.P., Chandrasekharan, M.B., Iuer, L.M., Li, G. and Hall, T.c. (1998). Genome intruder scanning and modulation systems and transgene silencing. Trends in Plant Sciences 3, 96-104. 46. See Pawlowski, W.P. and Somers, D.A. (1996). Transgene inheritance in plants. Molecular Biotechnology 6, 17-30. 47. Reviewed by Doerfler, W., Schubbert, R., Heller, H., Kammer, C., Hilger-Eversheim, D., Knoblauch, M. and Remus, R. (1997). Integration of foreign DNA and its consequences in mammalian systems. Tibtech 15, 297-301. 48. Draft Guidance for Industry: Use of Antibiotic Resistance Marker Genes in Transgenic Plants, US FDA, September 4, 1998. 49. See Letter from N. Tomlinson, Joint Food Safety and Standards Group, MAFF, to US FDA,